methods) induced a LTD of excitatory transmission onto D1R MSNs (Fig. 4E) . Consistent with previous studies, the magnitude of this LTD was enhanced in cocaine-treated as compared to saline-treated animals (41, 42) . However, in cocaine-treated animals that underwent SCH23390 exposure in combination with 12-Hz DBS 24 hours before being killed, this enhanced mGluR1 LTD was occluded, suggesting a shared mechanism between DBS and DHPG-induced LTD. Finally, cocaine exposure occludes the ability of high-frequency stimulation (HFS) to induce a LTP in D1R MSNs (15) . SCH23390 in combination with 12-Hz DBS rescued HFS LTP in cocaine treated animals, further suggesting that DBS induces a depotentiation in vivo (Fig. 4F) .
We used insight obtained from optogenetic in vivo manipulations to propose a novel DBS protocol, which efficiently abolishes behavioral sensitization to cocaine through the reversal of cocaine-evoked potentiation of excitatory transmission onto D1R MSNs. Classical high-frequency DBS does not alter cocaine-evoked plasticity and has only transient effects on locomotor sensitization; its behavioral effects are mediated through a mechanism that remains elusive. Low-frequency DBS applied on its own fails to affect drug-evoked plasticity, most likely because it causes release from dopamine terminals, due to the nonspecific nature of electrical stimulation. Only the combination of acute low-frequency DBS with a D1R antagonist (optogenetically inspired DBS) then enables the induction of the mGluR1 LTD necessary for the depotentation of synapses on D1R MSNs, most likely formed by the projections from the mPFC (18) , and abolishment of the drug-adaptive behavior. Given that SCH39166 is a U.S. Food and Drug Administration-approved D1R antagonist (43) , translational studies in humans may be feasible.
Our results demonstrate the potential of novel DBS protocols inspired by optogenetic manipulations of synaptic pathology. Using DBS to correct synaptic pathology and restore normal behavior may have applications in other neuropsychiatric disorders. Given the obstacles to the rapid translation of optogenetic interventions to humans (44) , these findings may lead to a full realization of the potential of novel DBS protocols. The phenotypic consequences of expression quantitative trait loci (eQTLs) are presumably due to their effects on protein expression levels. Yet the impact of genetic variation, including eQTLs, on protein levels remains poorly understood. To address this, we mapped genetic variants that are associated with eQTLs, ribosome occupancy (rQTLs), or protein abundance (pQTLs). We found that most QTLs are associated with transcript expression levels, with consequent effects on ribosome and protein levels. However, eQTLs tend to have significantly reduced effect sizes on protein levels, which suggests that their potential impact on downstream phenotypes is often attenuated or buffered. Additionally, we identified a class of cis QTLs that affect protein abundance with little or no effect on messenger RNA or ribosome levels, which suggests that they may arise from differences in posttranslational regulation.
T o understand the links between genetic and phenotypic variation, it may be essential to first understand how genetic variation impacts the regulation of gene expression. Previous studies have evaluated the association between variation and transcript expression in humans (1) (2) (3) . Yet protein abundances are more direct determinants of cellular functions (4) , and the impact of genetic differences on the multistage process of gene expression through transcription and translation to steady-state protein levels has not been fully characterized. Studies in model organisms have shown that variations in mRNA and protein expression levels are often uncorrelated (5) (6) (7) (8) . Comparative studies (9-13) have suggested that protein expression evolves under greater evolutionary constraint than transcript levels (14) and have provided evidence consistent with buffering of protein expression with respect to variation introduced at the transcript level. Yet, in contrast to comparative work, there are few reports of quantitative trait loci (QTLs) associated with protein levels (pQTLs) in humans (15) (16) (17) .
Here, we present a unified analysis of the association of genetic variation with transcript expression, ribosome profiling (18) , and steadystate protein levels in a set of HapMap Yoruba (Ibadan, Nigeria) lymphoblastoid cell lines (LCLs). We collected ribosome profiling data for 72 Yoruba LCLs and quantified protein abundance in 62 of these lines. Genome-wide genotypes and RNAsequencing (RNAseq) data were available for all lines (19) .
Ribosome profiling is an effective way to measure changes in translational regulation by using sequencing (18) . We obtained a median coverage of 12 million mapped reads per sample, and as expected, the ribosome profiling reads are highly concentrated within coding regions and show an enrichment of a 3-base pair (bp) periodicity, which reflects the progression of a translating ribosome (figs. S1 to S3 and table S1).
We collected relative protein expression measurements using a SILAC internal standard sample (20) and quantitative protein mass spectrometry ( fig. S4 ). To confirm the quality of the proteomics data (tables S2 and S3), we evaluated the agreement between measurements of distinct groups of peptides from the same protein.
Differences between these measurements can reflect true biological variation (e.g., splicing) or experimental noise. The high correlations (Spearman's rho 0.7 to 0.9; R 2 of 0.3 to 0.7; depending on the sample) confirmed that we are able to precisely quantify interindividual variation in protein levels ( fig. S5 ). We also analyzed quantifications of peptides that overlapped nonsynonymous SNPs that were heterozygous in either the analyzed or the internal standard sample (fig. S6 ). The median ratios measured from these peptides matched the expected values closely, indicating that our protein measurements were likely not subject to ratio compression (figs. S7 and S8).
As a final quality check, we considered variation in expression levels within and between genes. We found that transcript and protein expression levels-which are the furthest removed processes studied here-are the least correlated (figs. S9 and S10). Our observations are in agreement with most high-throughput studies that considered large number of samples, although smaller studies have often observed higher correlations (18, 21, 22) .
We mapped genetic associations with regulatory phenotypes. First, we evaluated QTLs for each phenotype independently by testing for association between the phenotype and all genetic variants with minor allele frequency >10% in a 20-kb window around the corresponding gene. We used a shared standardization, normalization, regression, and permutation pipeline for all three phenotypes. At a false discovery rate (FDR) of 10%, we detected 2355 eQTLs, 939 rQTLs, and 278 pQTLs (Table 1 and fig. S11 ).
There is substantial overlap among detected QTLs ( fig. S12) . Among the 4322 genes quantified for all three phenotypes, 54% of the genes with pQTLs also have a significant rQTL and/or eQTL. Given the incomplete statistical power detected for the phenotype labeled on each row were tested in the phenotype listed for each column, considering only the 4322 genes quantified in all three phenotypes. (C) On average, eQTLs exhibit attenuated effects on protein abundance but not on ribosome occupancy. We used eQTLs detected by the GEUVADIS study to avoid ascertainment bias, and we polarized the alleles according to the direction of effect in GEUVADIS. Mean effect sizes and standard errors of the means, measured as expected fold-change per allele copy on a log 2 scale.
to detect QTLs in each dataset independently, we performed replication testing across data sets, using the specific single-nucleotide polymorphism (SNP)-gene pairs underlying each class of QTLs. This analysis is less sensitive to power limitations than genome-wide testing. The results confirm that many QTLs are shared across all three phenotypes (example in Fig. 1A ). In particular, most (90%) genetic variants associated with ribosome occupancy are also associated with transcript levels ( fig. S13 ). In contrast, eQTLs showed the lowest overlap with pQTLs (35%), as expected (Fig. 1B) . Our observation that many SNPs identified as eQTLs are not associated with differences in protein levels is consistent with the notion that, across species, protein levels diverge less than transcript levels (12) (13) (14) (15) (16) (17) . Yet some QTLs may not replicate at the protein level simply because of incomplete mapping power. To address this and to avoid overestimation of effect sizes due to ascertainment bias at significant QTLs, we focused on eQTLs detected previously in European samples by the GEUVADIS study (2) . We then attempted to replicate the GEUVADIS eQTLs using our transcript, ribosome profiling, and protein data and considered the mean QTL effect size in each data type. Mean effect sizes calculated in this way are expected to be unbiased with respect to either technical or biological variance.
Using this approach, we observed a reduced mean effect size for the GEUVADIS eQTLs in the protein data compared with either the RNAseq data (t test P = 6.7 × 10 ) (Fig. 1C) . In contrast, the average effect sizes observed for the RNAseq and ribosome data are not significantly different from each other, and their effect sizes are highly correlated across the tested eQTLs (Pearson c = 0.79, P < 10 −96 ) ( fig. S14 ). The reduction in effect size observed in protein data is robust with respect to potential technical confounders, including intensity-based absolute quantification intensity level and transcript model complexity ( fig.  S15 ). We thus conclude that the majority of genetic variants affecting transcript levels also alter ribosomal occupancy, typically with a similar magnitude of effect. Yet both QTL mapping and effect-size analyses indicate that many eQTLs have attenuated (or absent) effects on steadystate protein levels ( fig. S16) .
In addition to the observation of generally attenuated effect sizes in pQTLs compared with eQTLs, we identified a subset of variants that appear to affect levels of proteins but not mRNA and, hence, are candidates to affect posttranscriptional gene regulation. To evaluate evidence for these, we tested each SNP for association with one regulatory phenotype, while treating one or both of the other phenotypes as covariates (conditional model). Considering protein levels, with RNA levels as a covariate, we identified 146 protein-specific QTLs (psQTLs) at FDR = 10% (Fig. 2A) . The identification of psQTLs is generally robust to the choice of technology used to characterize transcript expression ( fig. S17 ). , interaction model; P = 5.1 × 10
, conditional model) in protein than mRNA and that the effect on protein is not mediated by either mRNA or ribosome occupancy (LRT, P = 2.1×10
−12 , conditional model). Plotting details as in Fig. 1A . Although the causal variant underlying this pQTL is unknown, several linked variants near the 3′ end of APOL2 are all strongly associated with protein levels, including rs8142325
shown here and missense variant rs7285167 [linear model coefficient b g = 0.83, P = 9.8 × 10
; LRT, P = 2.1 × 10
, interaction model; P = 5.5×10 Using an alternative approach, an interaction model, we identified 68 psQTLs with significantly larger effects in protein than mRNA [according to a likelihood ratio test (LRT)] (FDR = 10%). We also used the interaction model to identify 76 expression-specific QTLs (esQTLs, interaction model, LRT; FDR = 10%). We then considered the ribosomal data. We found that the effect sizes for ribosomal occupancy are similar to the esQTL effect sizes (Fig. 2B ). Yet, for psQTLs, low ribosome effect sizes are observed. Thus, for QTLs with discordant effects between transcript and protein, the ribosome data usually tracked with levels of RNA. Put together, these results allow us to identify loci where genetic variants have specific impacts on protein levels that are not fully mediated by regulation of either transcription or translation and hence may affect rates of protein degradation.
Finally, we performed enrichment analysis in which we considered each tested gene-SNP pair separately and evaluated the full distribution of P values from the conditional model (rather than choosing a significance threshold) for different genomic and functional annotations. SNPs within transcribed regions [exonic and in the untranslated region (UTR)] are enriched for more significant psQTL effects, compared with intergenic or intronic SNPs, even within the narrow 20-kb windows tested (figs. S18 to S20). In addition, psQTLs are further enriched for nonsynonymous sites (compared with all exonic SNPs) ( Table 2) .
Investigating additional annotations (Table 2  and fig. S21 ), we found that nonsynonymous SNPs near acetylation sites showed nominal enrichment for psQTLs. This possibly reflects the functional role of lysine acetylation in modulating protein degradation (23) . Overall, the enrichment results suggest that genetic variants involved in posttranscriptional regulation are functionally distinct from genetic variants that primarily affect transcription-they are more likely to fall within translated regions of the gene and more likely to occur at nonsynonymous sites.
In summary, we have shown that, although a substantial fraction of regulatory genetic variants influence gene expression at all levels from mRNA to steady-state protein abundance, there are also a number of effects with specific impact on particular expression phenotypes. QTLs affecting mRNA levels are, on average, attenuated or buffered at the protein level, as has been observed between species (14) . Our analysis indicates that this attenuation is not evident at the stage of translation. Although the overall phenotypic similarity between ribosome occupancy and protein abundance is high, cis-regulatory genetic effects on ribosome occupancy appear to be more strongly shared with mRNA than with protein. These observations, along with the phenotype-specific QTL analysis, indicate a scarcity of translationspecific QTLs and minimal attenuation of genetic impact between mRNA and ribosome phenotypes. 
